University of Utah

Compiled by PlainTrial · August 8, 2026

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Utah sits in the top decile of US sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count).

818 total trials 138 currently recruiting 492 completed early-phase tilt top decile by trial count

University of Utah: 818 sponsored US clinical trials, 138 recruiting.

University of Utah sponsors 818 registered US clinical trials on ClinicalTrials.gov, 138 of them currently recruiting, and 492 completed. 45 of these trials are in Phase 3-4 (later-stage) and 268 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Low Back Pain, with 8 trials.

University of Utah ranks in the top decile of sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 41/100

492 of 611 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

818 total, page 2 of 17

University of Utah

Top-decile sponsor footprint

Open and recent trials

Investigating Changes in Premonitory Urges During Habit Reversal Training for Tics

Capturing Autobiographical Memory Formation in Real World Spaces Using Multimodal Recordings

XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer

MicroRNA Regulation of Chronic Inflammation During Aging

HPV Self-Collection Program

Physiology of Unloading VA ECMO Trial

Evaluation of a Structurally Suitable Neck Exoskeleton in Patients With Amyotrophic Lateral Sclerosis

Machine Learning Approaches to Personalized Therapy for Advanced Non-small Cell Lung Cancer With Real-World Data

Metformin and Muscle Recovery

Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type

LEADing Dementia End-of-Life Planning Conversations

Real-time Examination of Skills and Coping Use in Teen's Everyday Lives

Behavioral Treatment for Nightmares in REM Sleep Behavior Disorder

Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients

Novel Hypoxia Imaging for Head and Neck Cancer: Imaging Phenotype for Personalized Treatment

Massage for GAD: Neuroimaging and Clinical Correlates of Response

Community Services Navigation to Advance Health Equity in Breast Cancer Screening

Rural Adult and Youth Sun Protection Study

One MORE for Chronic Pain in Latinos

Tumor Treating Fields for Locally Advanced NSCLC

Clinical Characteristics and Temporal Properties of Individual Tics in Persistent Tic Disorder

Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma

Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion

Guided Meditation During Radiation Therapy for Brain Tumors

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies

Effect of Sleep Extension on Ceramides in People with Overweight and Obesity

Shoulder RFA Pilot Study

Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple Sclerosis

Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial

The Acute T-Rex (Timing of Resistance Exercise) Study

Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression

Improving Health Insurance Literacy Among Young Adult Cancer Survivors

National Institute of Diabetes and Digestive Kidney Diseases* Share Plus: Continuous Glucose Monitoring with Data Sharing in Older Adults with Type 1 Diabetes* and Their Care Partners to Improve Time in Range and Reduce Diabetes Distress.

Progression of Early Atrophic Lesions

Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies

Shared Decision for Drug Interactions in Oral Anticoagulation

5-HTP and Creatine for Depression R33 Phase

Effects of Clear Speech on Listening Effort and Memory in Sentence Processing

Allogeneic Hematopoietic Cell Transplantation With Pegylated Interferon Alfa-2a for Primary and Secondary Myelofibrosis

Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer

Circadian Intervention to Improve Cardiometabolic Health

Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant

Trident Multi-tined Cannula for Cervical MBRFA Compared to the Conventional Cannula

Undergraduate Skin Cancer Prevention Trial

Maternal Mental Health Access - MaMa

Metformin for Fibromyalgia Symptoms (INFORM Trial)

PCMS Task After Moderate-to-severe Stroke

Warfarin Patient Self-management Implementation in the US Healthcare System

Sex Hormone Supplementation and Rotator Cuff Repair: A Preliminary Randomized Trial

Phase Distribution

Therapeutic Areas

What is open in the University of Utah pipeline

University of Utah: open-pipeline peers nationwide

Sponsors near 818 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

Related